Research and Markets has announced the addition of the "Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" report to their offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Human Papillomavirus Diagnostic Tests pipeline products.

Scope

- Extensive coverage of the Human Papillomavirus Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Human Papillomavirus Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Products under Development

4 Human Papillomavirus Diagnostic Tests - Pipeline Products under Development by Companies

5 Human Papillomavirus Diagnostic Tests Companies and Product Overview

6 Human Papillomavirus Diagnostic Tests - Recent Developments

7 Appendix

Companies Mentioned

  • AutoGenomics, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biocartis SA
  • Biomagnetics Diagnostics Corporation
  • Bioorganic Research and Services S.A.
  • Bio-Techne Corp
  • Cepheid
  • China Medical Technologies, Inc.
  • Chronix Biomedical, Inc.
  • Co-Diagnostics

For more information about this report visit http://www.researchandmarkets.com/research/b96rnl/human